Pfizer says it raked in $36.8 billion in COVID-19 vaccine sales in 2021, making it among the best-selling drugs in history, and representing 45% of their product sales, which is projected to reach $100 billion in Q4 2022 [1]
Pfizer is expected to take their new mRNA technology, that has been “accepted” by the global population through the emergency use authorisation, and expand it into other diseases in collaboration with CODEX DNA. Acuitas Lipid Nanoparticles is also “an essential part of everything you do with mRNA” says Pfizer [2]